Enanta Pharmaceuticals Reports Financial Results for its Fourth Quarter and Year Ended September 30, 2017
Go back to Enanta Pharmaceuticals Reports Financial Results for its Fourth Quarter and Year Ended September 30, 2017| ENANTA PHARM (NASDAQ: ENTA) | Delayed: 14.06 +0.69 (5.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.37 | 52 Week High | $34.49 | |||
| Open | $13.22 | 52 Week Low | $20.39 | |||
| Day High | $14.12 | P/E | N/A | |||
| Day Low | $12.92 | EPS | $-3.18 | |||
| Volume | 401,621 | |||||

